Article
scRNA-Seq-based drug repurposing targeting idiopathic pulmonary fibrosis (IPF)
2022-09-17
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease, which affects around three million people worldwide and is characterized by impaired regeneration from recurrent injury to the alveolar epithelium resulting in progressive lung scarring. In this work, we target a cell transition in the differentiation of AT2 cells into mature AT1 cells which is inhibited in IPF and contributes to the regeneration of th...
Topics
Open a Topic to create a Post that cites this publication.
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Extracellular vesicles in disease
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Neonatal Respiratory Health Research
- Systemic Sclerosis and Related Diseases
Identifiers and source
- Literature Corpus work
- 20955b8e-eced-5a1a-8b37-c32416de99e9
- DOI
- 10.1101/2022.09.17.508360
